|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1995-4-7
|
|
pubmed:abstractText |
Interleukin-6 (IL-6) is a potent immunomodulatory cytokine that may have pathogenetic and prognostic significance in a number of disorders. The objective of this study was to examine the correlation between serum IL-6 levels and phenotypic characteristics, as well as outcome of patients with diffuse large-cell lymphoma (DLCL).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
575-82
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:7884418-Adult,
pubmed-meshheading:7884418-Aged,
pubmed-meshheading:7884418-Blood Sedimentation,
pubmed-meshheading:7884418-Disease-Free Survival,
pubmed-meshheading:7884418-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:7884418-Female,
pubmed-meshheading:7884418-Humans,
pubmed-meshheading:7884418-Interleukin-6,
pubmed-meshheading:7884418-Least-Squares Analysis,
pubmed-meshheading:7884418-Leukocyte Count,
pubmed-meshheading:7884418-Lymphoma, Large B-Cell, Diffuse,
pubmed-meshheading:7884418-Male,
pubmed-meshheading:7884418-Middle Aged,
pubmed-meshheading:7884418-Platelet Count,
pubmed-meshheading:7884418-Prognosis,
pubmed-meshheading:7884418-Regression Analysis,
pubmed-meshheading:7884418-Serum Albumin,
pubmed-meshheading:7884418-Survival Rate,
pubmed-meshheading:7884418-beta 2-Microglobulin
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
Serum interleukin-6 levels correlate with prognosis in diffuse large-cell lymphoma.
|
|
pubmed:affiliation |
Department of Clinical Investigation, M.D. Anderson Cancer Center, Houston, TX 77030.
|
|
pubmed:publicationType |
Journal Article
|
